-
1
-
-
34547127401
-
Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor
-
DOI 10.1016/j.jaci.2007.04.028, PII S0091674907008640
-
Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor. L Schneider, W Lumry, A Vegh, AH Williams, T Schmalbach, J Allergy Clin Immunol 2007 120 2 416 22 10.1016/j.jaci.2007.04.028 17559913 (Pubitemid 47102386)
-
(2007)
Journal of Allergy and Clinical Immunology
, vol.120
, Issue.2
, pp. 416-422
-
-
Schneider, L.1
Lumry, W.2
Vegh, A.3
Williams, A.H.4
Schmalbach, T.5
-
2
-
-
73249128396
-
Pathogenesis and laboratory diagnosis of hereditary angioedema
-
10.2500/aap.2009.30.3277 19843402
-
Pathogenesis and laboratory diagnosis of hereditary angioedema. BL Zuraw, SC Christiansen, Allergy Asthma Proc 2009 30 5 487 92 10.2500/aap.2009.30.3277 19843402
-
(2009)
Allergy Asthma Proc
, vol.30
, Issue.5
, pp. 487-92
-
-
Zuraw, B.L.1
Christiansen, S.C.2
-
3
-
-
0036139317
-
Hereditary angioedema as a cause of transient abdominal pain
-
DOI 10.1097/00004836-200201000-00011
-
Hereditary angioedema as a cause of transient abdominal pain. UC Nzeako, E Frigas, WJ Tremaine, J Clin Gastroenterol 2002 34 1 57 61 10.1097/00004836- 200201000-00011 11743247 (Pubitemid 34038481)
-
(2002)
Journal of Clinical Gastroenterology
, vol.34
, Issue.1
, pp. 57-61
-
-
Nzeako, U.C.1
Frigas, E.2
Tremaine, W.J.3
-
4
-
-
39049122335
-
Benefits and risks of danazol in hereditary angioedema: A long-term survey of 118 patients
-
Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. K Bork, J Hardt, Ann Allergy Asthma Immunol 2008 100 2 153 61 10.1016/S1081-1206(10)60424-3 18320917 (Pubitemid 351238551)
-
(2008)
Annals of Allergy, Asthma and Immunology
, vol.100
, Issue.2
, pp. 153-161
-
-
Bork, K.1
Bygum, A.2
Hardt, J.3
-
5
-
-
66249101207
-
When is prophylaxis for hereditary angioedema necessary?
-
10.1016/S1081-1206(10)60506-6 19492656
-
When is prophylaxis for hereditary angioedema necessary? T Craig, M Riedl, MS Dykewicz, RG Gower, J Baker, FJ Edelman, D Hurewitz, J Jacobs, I Kalfus, Ann Allergy Asthma Immunol 2009 102 5 366 72 10.1016/S1081-1206(10) 60506-6 19492656
-
(2009)
Ann Allergy Asthma Immunol
, vol.102
, Issue.5
, pp. 366-72
-
-
Craig, T.1
Riedl, M.2
Dykewicz, M.S.3
Gower, R.G.4
Baker, J.5
Edelman, F.J.6
Hurewitz, D.7
Jacobs, J.8
Kalfus, I.9
-
6
-
-
34147199441
-
Fresh frozen plasma for the treatment of hereditary angioedema
-
Fresh frozen plasma for the treatment of hereditary angioedema. M Prematta, JG Gibbs, EL Pratt, TR Stoughton, TJ Craig, Ann Allergy Asthma Immunol 2007 98 4 383 8 10.1016/S1081-1206(10)60886-1 17458436 (Pubitemid 46582131)
-
(2007)
Annals of Allergy, Asthma and Immunology
, vol.98
, Issue.4
, pp. 383-388
-
-
Prematta, M.1
Gibbs, J.G.2
Pratt, E.L.3
Stoughton, T.R.4
Craig, T.J.5
-
7
-
-
73249115775
-
Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks
-
10.2500/aap.2009.30.3279 19843405
-
Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. MJ Prematta, JG Kemp, JG Gibbs, C Mende, C Rhoads, TJ Craig, Allergy Asthma Proc 2009 30 5 506 11 10.2500/aap.2009.30.3279 19843405
-
(2009)
Allergy Asthma Proc
, vol.30
, Issue.5
, pp. 506-11
-
-
Prematta, M.J.1
Kemp, J.G.2
Gibbs, J.G.3
Mende, C.4
Rhoads, C.5
Craig, T.J.6
-
8
-
-
43349099321
-
New treatments addressing the pathophysiology of hereditary angioedema
-
DOI 10.1186/1476-7961-6-2
-
New treatments addressing the pathophysiology of hereditary angioedema. AE Davis, Clin Mol Allergy 2008 6 2 10.1186/1476-7961-6-2 18410689 (Pubitemid 351659542)
-
(2008)
Clinical and Molecular Allergy
, vol.6
, pp. 2
-
-
Davis III, A.E.1
-
9
-
-
52249103874
-
Absolute Bioavailability of Subcutaneously Administered Icatibant, a Selective and Potent Bradykinin B2 Receptor Antagonist
-
10.1016/j.jaci.2006.12.441
-
Absolute Bioavailability of Subcutaneously Administered Icatibant, a Selective and Potent Bradykinin B2 Receptor Antagonist. F Wagner, B Rosenkranz, J Knolle, J Allergy Clin Immunol 2007 119 274 10.1016/j.jaci.2006.12.441
-
(2007)
J Allergy Clin Immunol
, vol.119
, pp. 19274
-
-
Wagner, F.1
Rosenkranz, B.2
Knolle, J.3
-
11
-
-
50949089029
-
Clinical practice. Hereditary angioedema
-
10.1056/NEJMcp0803977 18768946
-
Clinical practice. Hereditary angioedema. BL Zuraw, N Engl J Med 2008 359 10 1027 36 10.1056/NEJMcp0803977 18768946
-
(2008)
N Engl J Med
, vol.359
, Issue.10
, pp. 1027-36
-
-
Zuraw, B.L.1
-
12
-
-
38049057736
-
Hereditary angioedema: A current state-of-the-art review, I: Introduction
-
18220144
-
Hereditary angioedema: a current state-of-the-art review, I: introduction. JA Bernstein, Ann Allergy Asthma Immunol 2008 100 S2 1 18220144
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
, Issue.S2
, pp. 191
-
-
Bernstein, J.A.1
-
14
-
-
65449188723
-
Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits
-
19264579
-
Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. A Bygum, KE Andersen, CS Mikkelsen, Eur J Dermatol 2009 19 2 147 51 19264579
-
(2009)
Eur J Dermatol
, vol.19
, Issue.2
, pp. 147-51
-
-
Bygum, A.1
Andersen, K.E.2
Mikkelsen, C.S.3
-
15
-
-
33646022921
-
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency
-
10.1016/j.jaci.2006.01.002 16630950
-
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. M Levi, G Choi, C Picavet, CE Hack, J Allergy Clin Immunol 2006 117 4 904 8 10.1016/j.jaci.2006.01.002 16630950
-
(2006)
J Allergy Clin Immunol
, vol.117
, Issue.4
, pp. 904-8
-
-
Levi, M.1
Choi, G.2
Picavet, C.3
Hack, C.E.4
-
16
-
-
0037456765
-
Preventing complications of central venous catheterization
-
DOI 10.1056/NEJMra011883
-
Preventing complications of central venous catheterization. D McGee, Gould Met, NEJM 2003 348 1123 1133 10.1056/NEJMra011883 12646670 (Pubitemid 36337324)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.12
, pp. 1123-1133
-
-
McGee, D.C.1
Gould, M.K.2
-
17
-
-
70449727672
-
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks
-
10.1016/j.jaci.2009.07.017 19767078
-
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. TJ Craig, RJ Levy, RL Wasserman, AK Bewtra, D Hurewitz, K Obtuowicz, A Reshef, B Ritchie, D Moldovan, T Shirov, V Grivcheva-Panovska, PC Kiessling, HO Keinecke, JA Bernstein, J Allergy Clin Immunol 2009 124 4 801 8 10.1016/j.jaci.2009.07.017 19767078
-
(2009)
J Allergy Clin Immunol
, vol.124
, Issue.4
, pp. 801-8
-
-
Craig, T.J.1
Levy, R.J.2
Wasserman, R.L.3
Bewtra, A.K.4
Hurewitz, D.5
Obtuowicz, K.6
Reshef, A.7
Ritchie, B.8
Moldovan, D.9
Shirov, T.10
Grivcheva-Panovska, V.11
Kiessling, P.C.12
Keinecke, H.O.13
Bernstein, J.A.14
|